Patents by Inventor Randell G. Young

Randell G. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230089901
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: September 23, 2022
    Publication date: March 23, 2023
    Inventors: Alla DANILKOVICH, Robert E. NEWMAN, Samson TOM, Christopher TON, Zhanling WANG, Randell G. YOUNG
  • Publication number: 20180008642
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: May 23, 2017
    Publication date: January 11, 2018
    Inventors: Alla Danilkovich, Robert E. Newman, JR., Samson Tom, Christopher Ton, Zhanling Wang, Randell G. Young
  • Publication number: 20140105872
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: December 16, 2013
    Publication date: April 17, 2014
    Inventors: Alla Danilkovich, Robert E. Newman, JR., Samson Tom, Christopher Ton, Zhanling Wang, Randell G. Young
  • Patent number: 8637004
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: January 28, 2014
    Assignee: Mesoblast International Sarl
    Inventors: Alla Danilkovich, Robert E. Newman, Jr., Samson Tom, Christopher Ton, Zhanling Wang, Randell G. Young
  • Publication number: 20100068191
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: August 14, 2009
    Publication date: March 18, 2010
    Inventors: Alla Danilkovich, Robert E. Newman, JR., Samson Tom, Christopher Ton, Zhanling Wang, Randell G. Young
  • Patent number: 6482231
    Abstract: A biological material for the repair of connective tissue cells comprising: a) a cell preparation enriched in mesenchymal stem cells, b) three-dimensional extracellular matrix comprising a nyaluronic acid derivative. The use of said biological material, optionally combined with therapeutically acceptable excipients and/or diluents and optionally in association with therapeutically effective ingredients in the repair of connective tissue cells.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: November 19, 2002
    Inventors: Giovanni Abatangelo, Lanfranco Callegaro, Randell G. Young, Josephine Mary Murphy, David Jordan Fink, Scott Philip Bruder, Francis Peter Barry, Sudhakar Kadiyala, Arnold I. Caplan, Roland Moskowitz, Jung U. Yoo, Luis A. Solchaga
  • Patent number: 5855619
    Abstract: An implant for repair of a tissue defect which implant comprises a physiologically compatible load-bearing member having an element for securing under tension tissue adjacent to the defect to be repaired, an element for supporting a tissue reparative cell mass in the defect and a tissue reparative cell mass supported thereby. The implant can be a suture material having a cell containing matrix surrounding a central portion thereof. The matrix is preferably a gel or other material which the cells cause to contract, thereby drawing together the tissues surrounding the defect to which the implant is attached.
    Type: Grant
    Filed: September 30, 1996
    Date of Patent: January 5, 1999
    Assignee: Case Western Reserve University
    Inventors: Arnold I. Caplan, David J. Fink, Randell G. Young